United States Next Generation Sequencing Market to grow at a Significant Rate through 2026
Advancements in technology
and increasing prevalence of cancer is expected to drive the demand for United
States next generation sequencing market for the forecast period.
According to TechSci Research report, “United
States Next Generation Sequencing Market By Product (Consumables,
Platforms, Services) By Technology (Sequencing by Synthesis, Ion Semiconductor
Sequencing, Sequencing by Ligation, Single Molecule Real Time Sequencing,
Others) By Application (Biomarkers & Cancer, Diagnostics, Reproductive
Health, Personalized Medicine, Agriculture & Animal Research, Others) By
End User (Academic & Clinical Research Centers, Pharmaceutical &
Biotechnology Companies, Hospitals & Clinics, Others) By Company, By
Region, Forecast & Opportunities, 2026”, The United States next
generation sequencing market is expected to witness significant growth for the
next five years. Advancement in platforms used for next generation sequencing
and lowering cost of genome sequencing is driving the growth of the market.
Continuous innovations in next generation sequencing have led to efficient,
easy to use platforms, rapid and accurate test results along with portability
which is influencing the demand of next generation sequencing technology in
United States. Increase in use of next generation sequencing for conducting
cancer research is further accelerating the growth of the market.
The COVID-19 outbreak across the world which has been
declared as pandemic by World Health Organization has affected countries
adversely. Leading authorities in United States imposed lockdown restrictions
and released a set of precautionary measures to contain the spread of novel
coronavirus. Coronavirus affected patients started suffering from shortness of
breath along with coughing and sneezing which created lucrative opportunities
for the growth of the next generation sequencings market. United States authorities
increased the capacity of hospitals as a greater number of patients were
getting affected daily and getting admitted into the hospital facilities. Genome
sequencing is used to understand the spread and map of evolution of
coronavirus. The study is further utilized in making effective drugs and
treatment of COVID-19. Major market players are investing to develop vaccines
and therapies to ensure the long-term treatment of COVID-19.
However, next generation sequencing is time-consuming
and less cost-effective for sequencing low number of targets ranging from 1-20
which may create hindrance in the growth of the next generation sequencing
market.
Browse XX Figures spread
through XX Pages and an in-depth TOC on "United States Next Generation Sequencing
Market”.
https://www.techsciresearch.com/report/united-states-next-generation-sequencing-market/7486.html
United
States next generation sequencing market is segmented into product, technology,
application, end user, regional distribution, and company. Based on application,
market is further divided into biomarkers & cancer, diagnostics,
reproductive health, personalized medicine, agriculture & animal research,
and others. The biomarkers & cancer segment is expected to hold major
market share for the forecast period, 2022-2026. Increasing prevalence of
cancer and supportive government policies is fueling the demand of next
generation sequencing market for the next five years. Next generation
sequencing coupled with bioinformatics tools is providing tremendous potential
for research and development and seeking effective ways for diagnosis and
treatment. Next generation sequencing is used in enhancing the genomic profile
of tumour samples which is expected to improve the treatment of cancer in long
run. Based on product, market is majorly categorized into consumables, platforms,
and services. The consumables segment is expected to dominate the market due to
introduction of easy-to-use consumables and increase in number of sequencing
procedures performed in United States. On the basis of technology analysis,
market is fragmented into sequencing by synthesis, ion semiconductor
sequencing, sequencing by ligation, single molecule real time sequencing and others.
The sequencing by synthesis segment is expected to hold major market share due
to high demand for next generation sequencing platforms based on sequencing by
synthesis technology.
Illumina,
Inc., Thermo Fischer Scientific, Inc., Roche Diagnostics Corporation, Agilent
Technologies, Inc., PerkinElmer Inc., Pacific Biosciences of California Inc,
10x Genomics Inc., Amgen Inc., Bio-Rad Laboratories, Inc., QIAGEN Inc. are the
leading players operating in United States next generation sequencing market. Service
providers are increasingly focusing on research and development process to fuel
higher growth in the market. To meet evolving customer demand with respect to
better efficiency and durability, several next generation sequencing providers are
coming up with their technologically advanced offerings.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7486
Customers can also
request for 10% free customization on this report.
“Rise
in use of Amplicon RNA-Seq technology for targeted RNA sequencing for diagnosis
procedurals is driving the growth of the market. Also, the availability of kits
for cardiotoxicity, cell cycle, apoptosis, among others is fueling the growth
of next generation sequencing demand. Launch of novel products by major players
such as providing platform for genetic screening and support from the
government for carrying out research and development activities is expected to
propel the next generation sequencing market growth until 2026” said Mr.
Karan Chechi, Research Director with TechSci Research, a research based global
management consulting firm.
“United States Next
Generation Sequencing Market By Product (Consumables, Platforms, Services) By
Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing
by Ligation, Single Molecule Real Time Sequencing, Others) By Application
(Biomarkers & Cancer, Diagnostics, Reproductive Health, Personalized
Medicine, Agriculture & Animal Research, Others) By End User (Academic
& Clinical Research Centers, Pharmaceutical & Biotechnology Companies,
Hospitals & Clinics, Others) By Company, By Region, Forecast &
Opportunities, 2026” has evaluated the future growth potential of United
States next generation sequencing market and provided statistics & information
on market size, shares, structure and future market growth. The report intends
to provide cutting-edge market intelligence and help decision makers take sound
investment decisions. Besides, the report also identifies and analyzes the
emerging trends along with essential drivers, challenges, and opportunities in the
of United States next generation sequencing market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Web:
https://www.techsciresearch.com/